235
Views
6
CrossRef citations to date
0
Altmetric
Articles

Subclinical executive function impairment in children with asymptomatic, treated phenylketonuria: A comparison with children with immunodeficiency virus

, ORCID Icon, &
Pages 200-208 | Received 15 Feb 2016, Accepted 19 Oct 2017, Published online: 09 Nov 2017

References

  • Anderson, P. J., & Leuzzi, V. (2010). White matter pathology in phenylketonuria⋆. Molecular Genetics and Metabolism, 99(Suppl 1), S3–S9. doi: 10.1016/j.ymgme.2009.10.005
  • Anderson, P., Wood, S., Francis, D., Coleman, L., Warwick, L., Casanelia, S., … Boneh, A. (2004). Neuropsychological functioning in children with early-treated phenylketonuria: Impact of white matter abnormalities. Dev. Med. Child Neurol, 46(2004), 230–238.
  • Astle, D. E., & Scerif, G. (2009). Using developmental cognitive neuroscience to study behavioral and attentional control. Developmental Psychobiology, 51(2), 107–118. doi: 10.1002/dev.20350
  • Aylward, G. P. (2005). Neurodevelopmental outcomes of infants born prematurely. Journal of Developmental & Behavioral Pediatrics, 26(6), 427–440. doi: 10.1097/00004703-200512000-00008
  • Azadi, B., Seddigh, A., Tehrani-Doost, M., Alaghband-Rad, J., & Ashrafi, M. R. (2009). Executive dysfunction in treated phenylketonuric patients. European Child & Adolescence Psychiatry, 18(6), 360–368. doi: 10.1007/s00787-009-0738-8
  • Banerjee, P., Grange, D. K., Steiner, R. D., & White, D. A. (2011). Executive strategic processing during verbal fluency performance in children with phenylketonuria. Child Neuropsychology, 17(2), 105–117. doi: 10.1080/09297049.2010.525502
  • Bettcher, B. M., Mungas, D., Patel, N., Elofson, J., Dutt, S., Wynn, M., … Kramer, J. H. (2016). Neuroanatomical substrates of executive functions: Beyond prefrontal structures. Neuropsychologia, 85, 100–109. doi: 10.1016/j.neuropsychologia.2016.03.001
  • Bisiacchi, P. S, Cendron, M, Gugliotta, M, Tressoldi, P, & Vio, C. (2005). BVN 5-11. Batteria di valutazioneneuropsicologica per l’eta’ evolutiva. Trento: Edizioni Erickson.
  • Bisiacchi, P. S., Suppiej, A., & Laverda, A. (2000). Neuropsychological evaluation of neurologically asymptomatic HIV-infected children. Brain and Cognition, 43(1–3), 49–52.
  • Blau, N., van Spronsen, F. J., & Levy, H. L. (2010). Phenylketonuria. Lancet, 376(2010), 1417–1427. doi: 10.1016/S0140-6736(10)60961-0
  • Christ, S. E., Huijbregts, S. C. J., de Sonneville, L. M. J., & White, D. A. (2010). Executive function in early-treated phenylketonuria: Profile and underlying mechanisms. Molecular Genetics and Metabolism, 99(Suppl 1), S22–S32. doi: 10.1016/j.ymgme.2009.10.007
  • Compistol, J., Gassiò, R., Artuch, R., & Vilaseca, M. A. (2011). Neurocognitive function in mild hyperphenylalaninemia. Developmental Medicine & Child Neurology, 53, 405–408. doi: 10.1111/j.1469-8749.2010.03869.x
  • Cona, G., Scarpazza, C., Sartori, G., Moscovitch, M., & Bisiacchi, P. S. (2015). Neural bases of prospective memory: A meta-analysis and the “attention to delayed intention” (AtoDI) model. Neuroscience & Biobehavioral Reviews, 52, 21–37. doi: 10.1016/j.neubiorev.2015.02.007
  • Diamond, A. (2007). Consequences of variations in genes that affect dopamine in prefrontal cortex. Cerebral Cortex, 17(1), i161–i170. doi: 10.1093/cercor/bhm082
  • Diamond, A., Ciaramitaro, V., Donner, E., Djali, S., & Robinson, M. B. (1994). An animal model of early-treated PKU. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 14(5), 3072–3082. doi: 10.1523/JNEUROSCI.14-05-03072.1994
  • Diamond, A., Prevor, M. B., Callender, G., & Druin, D. P. (1997). Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs of the Society for Research in Child Development, 62(4), i–v, 1–208. doi: 10.2307/1166208
  • Donders, J., & Taneja, C. (2009). Neurobehavioral characteristics of children with duchenne muscular dystrophy. Child Neuropsychology : A Journal on Normal and Abnormal Development in Childhood and Adolescence, 15(3), 295–304. doi: 10.1080/09297040802665777
  • Duncan, J., Emslie, H., Williams, P., Johnson, R., & Freer, C. (1996). Intelligence and the frontal lobe: The organization of goal-directed behavior. Cognitive Psychology, 30, 257–303. doi: 10.1006/cogp.1996.0008
  • Ellis, R. J., Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., & Clifford, D., The CHARTER Group. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. Aids (london, England), 25, 1747–1751. doi: 10.1097/QAD.0b013e32834a40cd
  • Ellis, R. J., Calero, P., & Stockin, M. D. (2009). HIV infection and the central nervous system: A primer. Neuropsychology Review, 19, 144–151. doi: 10.1007/s11065-009-9094-1
  • Feldman, R., Denecke, J., Pietsch, M., Grenzebach, M., & Weglage, J. (2002). Phenylketonuria: No specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics. Pediatric Research, 51(6). 761–765. doi:10.1023/01.PDR.0000017479.64723.30 doi: 10.1203/00006450-200206000-00017
  • Fuster, J. M. (1997). The prefrontal cortex: Anatomy, physiology and neurophysiology of the frontal lobe. New York: Lippincott-Raven Press.
  • Goldman-Rakic, P. S. (1995). Architecture of the prefrontal cortex and the central executive. Annals of the New York Academy of Sciences, 769, 71–84. doi: 10.1111/j.1749-6632.1995.tb38132.x
  • Gugliotta, M, Bisiacchi, P. S, Cendron, M, Tressoldi, P, & Vio, C. (2009). BVN 12-18. Batteria di Valutazione Neuropsicologica per l’adolescenza. Trento: Edizioni Erickson.
  • Hood, A., Antenor-Dorsey, J. A. V., Rutlin, J., Hershey, T., Shimony, J. S., McKinstry, R. C., & White, D. A. (2015). Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria. Molecular Genetics and Metabolism, 114(1), 19–24. doi: 10.1016/j.ymgme.2014.11.007
  • Huijbregts, S. C., de Sonneville, L. M., Licht, R., van Spronsen, F. J., & Sergeant, J. A. (2002). Short-term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well-controlled population. Journal of Inherited Metabolic Disease, 25(6), 419–430. doi: 10.1023/A:1021205713674
  • Huijbregts, S. C. J., Gassió, R., & Campistol, J. (2013). Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria. Molecular Genetics and Metabolism, 110(Suppl), S25–S30. doi: 10.1016/j.ymgme.2013.10.001
  • Jahja, R., Huijbregts, S. C. J., de Sonneville, L. M. J., van der Meere, J. J., & van Spronsen, F. J. (2014). Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria. The Journal of Pediatrics, 164(4), 895–899.e2. doi: 10.1016/j.jpeds.2013.12.015
  • Koekkoek, S., De Sonneville, L. M. J., Wolfs, T. F. W., Licht, R., & Geelen, S. P. M. (2008). Neurocognitive function profile in HIV-infected school-age children. European Journal of Paediatric Neurology, 12, 290–297. doi: 10.1016/j.ejpn.2007.09.002
  • Le Bihan, D. (2003). Looking into the functional architecture of the brain with diffusion MRI. Nature Reviews Neuroscience, 4(6), 469–480. doi: 10.1038/nrn1119
  • Leuzzi, V., Pansini, M., Sechi, E., Chiarotti, F., & Carducci, C. (2004). Executive function impairment in early-treated PKU subjects with normal mental development. Journal of Inherited Metabolic Disease, 27(2), 115–125. doi: 10.1023/B:BOLI.0000028781.94251.1f
  • Lokken, K. L., Boeka, A. G., Austin, H. M., Gunstad, J., & Harmon, C. M. (2009). Evidence of executive dysfunction in extremely obese adolescents: A pilot study. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, 5(5), 547–552. doi: 10.1016/j.soard.2009.05.008
  • Lou, H. C., Lykkelund, C., Gerdes, A. M., Udesen, H., & Bruhn, P. (1987). Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatrica, 76(4), 560–565. doi: 10.1111/j.1651-2227.1987.tb10521.x
  • Mastrangelo, M., Chiarotti, F., Berillo, L., Caputi, C., Carducci, C., Di Biasi, C., & Leuzzi, V. (2015). The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Molecular Genetics and Metabolism, 116(3), 171–177. doi: 10.1016/j.ymgme.2015.08.005
  • Mento, G., & Bisiacchi, P. S. (2012). Neurocognitive development in preterm infants: Insights from different approaches. Neuroscience and Biobehavioral Reviews, 36(1), 536–555. doi: 10.1016/j.neubiorev.2011.08.008
  • Mento, G., Tarantino, V., & Bisiacchi, P. S. (2011). The neuropsychological profile of infantile duchenne muscular dystrophy. Clinical Neuropsychologist, 25(8), 1359–1377. doi: 10.1080/13854046.2011.617782
  • Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent variable analysis. Cognitive Psychology, 41(1), 49–100. doi: 10.1006/cogp.1999.0734
  • Moscovitch, M. (1992). Memory and working-with-memory: A component process model based on modules and central systems. Journal of Cognitive Neuroscience, 4, 257–267. doi: 10.1162/jocn.1992.4.3.257
  • Nardecchia, F., Manti, F., Chiarotti, F., Carducci, C., Carducci, C., & Leuzzi, V. (2015). Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study. Molecular Genetics and Metabolism, 115(2–3), 84–90. doi: 10.1016/j.ymgme.2015.04.003
  • Palermo, L., Geberhiwot, T., MacDonald, A., Limback, E., Hall, S. K., & Romani, C. (2017). Cognitive outcomes in early treated adults with phenylketonuria (PKU): A comprehensive picture across domains. Neuropsychology, 31, 255–267. doi: 10.1037/neu0000337
  • Peng, H., Peck, D., White, D. A., & Christ, S. E. (2014). Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria. Journal of Inherited Metabolic Disease, 37(2), 237–243. doi: 10.1007/s10545-013-9650-y
  • Petrides, M. (2005). Lateral prefrontal cortex: Architectonic and functional organization. Philosophical Transactions of the Royal Society B: Biological Sciences, 29;360(1456), 781–795. doi: 10.1098/rstb.2005.1631
  • Phillips, N., Amos, T., Kuo, C., Hoare J., Ipser J., Thomas K. G. F., & Stein D. J. (2016). HIV-Associated Cognitive impairment in perinatally infected children: A meta-analysis. Pediatrics, 138(5), e20160893. doi: 10.1542/peds.2016-0893
  • Rasmussen, C., Wyper, K., & Talwar, V. (2009). The relation between theory of mind and executive functions in children with fetal alcohol spectrum disorders. The Canadian Journal of Clinical Pharmacology, 16(2), e370–e380.
  • Romani, C., MacDonald, A., De Felice, S., & Palermo, L. (2017). Speed of processing and executive functions in adults with phenylketonuria: Quick in finding the word, but not the ladybird. Cognitive Neuropsychology. doi:10.1080/02643294.2017.1320278
  • Romani, C., Palermo, L., MacDonald, A., Limback, E., Hall, S. K., & Geberhiwot, T. (2017). The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages. Neuropsychology, 31, 242–254. http://doi.org/10.1037/neu0000 doi: 10.1037/neu0000336
  • Safriel, Y. I., Haller, J. O., Lefton, D. R., & Obedian, R. (2000). Imaging of the brain in the HIV-positive child. Pediatric Radiology, 30(11), 725–732. doi: 10.1007/s002470000338
  • Smith, R., & Wilkins, M. (2015). Perinatally acquired HIV infection: Long-term neuropsychological consequences and challenges ahead. Child Neuropsychology, 21(2), 234–268. doi: 10.1080/09297049.2014.898744
  • Stevenson, M., & McNaughton, N. (2013). A comparison of phenylketonuria with attention deficit hyperactivity disorder: Do markedly different aetiologies deliver common phenotypes? Brain Research Bulletin, 99, 63–83. doi: 10.1016/j.brainresbull.2013.10.003
  • Stuss, D. T., & Benson, D. F. (1986). The frontal lobes. New York: Raven Press.
  • Unterrainer, J. M., Kaller, C. P., Loosli, S. V., Heinze, K., Ruh, N., Paschke-Müller, M., … Rahm, B. (2015). Looking ahead from age 6 to 13: A deeper insight into the development of planning ability. British Journal of Psychology, 106(1), 46–67. doi: 10.1111/bjop.12065
  • Vallesi, A. (2012). Organisation of executive functions?: hemispheric asymmetries invited address at the occasion of the bertelson award 2011 organisation of executive functions: Hemispheric asymmetries. Journal of Cognitive Psychology, 24(4), 367–386. doi: 10.1080/20445911.2012.678992
  • Walker, K. A., & Brown, G. G. (2017). HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis. Journal of Clinical and Experimental Neuropsychology, 18, 1–20. doi: 10.1080/13803395.2017
  • Welsh, M. C. (1996). A prefrontal dysfunction model of early-treated phenylketonuria. European Journal of Pediatrics, 155(Suppl), S87–S89. doi: 10.1007/PL00014259
  • Welsh, M., & Pennington, B. (1988). Assessing frontal lobe functioning in children: Views from developmental psychology. Developmental Neuropsychology, 4(3), 199–230. doi: 10.1080/87565648809540405
  • Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. (1990). Neuropsychology of early-treated phenylketonuria: Specific executive function deficits. Child Development, 61(6), 1697–1713. doi: 10.2307/1130832
  • White, D. A., Antenor-Dorsey, J. A. V., Grange, D. K., Hershey, T., Rutlin, J., Shimony, J. S., … Christ, S. E. (2013). White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria. Molecular Genetics and Metabolism, 110(3), 213–217. doi: 10.1016/j.ymgme.2013.07.010
  • White, D. A., Nortz, M. J., Mandernach, T., Huntington, K., & Steiner, R. D. (2002). Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria. Journal of the International Neuropsychological Society, 8(1), 1–11. doi: 10.1017/S1355617702811018
  • Wicksell, R. K., Kihlgren, M., Melin, L., & Eeg-Olofsson, O. (2004). Specific cognitive deficits are common in children with duchenne muscular dystrophy. Developmental Medicine and Child Neurology, 46(3), 154–159. doi: 10.1111/j.1469-8749.2004.tb00466.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.